Showing results (281-290 of 340) with videos related to
Sort By:
Pageof 34
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
Use of carrier cells to deliver a replication-selective herpes simplex virus-1 mutant for the intraperitoneal therapy of epithelial ovarian cancerG Coukos, A Makrigiannakis, E H Kang, et al.Journal of the National Cancer Institute|June 13, 1998
Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutationsJ O Schorge, M G Muto, W R Welch, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 1991
Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatinM Markman, R Rothman, T Hakes, et al.Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|January 8, 1998
In vivo forces during remodeling of a two-segment anterior cruciate ligament graft in a goat modelW R Lundberg, J L Lewis, J J Smith, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1991
Persistent hypomagnesemia following cisplatin chemotherapy in patients with ovarian cancerM Markmann, R Rothman, B Reichman, et al.Gynecologic Oncology|June 11, 1991
Late effects of cisplatin-based chemotherapy on renal function in patients with ovarian carcinomaM Markman, R Rothman, T Hakes, et al.Journal of Applied Microbiology|March 14, 2015
Development and utility of the FDA 'GutProbe' DNA microarray for identification, genotyping and metagenomic analysis of commercially available probioticsJ N Patro, P Ramachandran, J L Lewis, et al.Gynecologic Oncology|November 11, 1991
Phase II trial of high-dose cisplatin with sodium thiosulfate nephroprotection in patients with advanced carcinoma of the uterine cervix previously untreated with chemotherapyB Reichman, M Markman, T Hakes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 1992
Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer: activity in platinum-resistant diseaseM Markman, T Hakes, B Reichman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
Phase II trial of intraperitoneal mitoxantrone in the management of refractory ovarian cancerM Markman, M George, T Hakes, et al.Pageof 34